Introduction

Advances in the treatment of acute myelogenous leukemia (AML) have resulted in improved remission and cure rates.

About 13,410 new cases of AML will be diagnosed in the United States in 2007 (source: Surveillance, Epidemiology and End Results [SEER] Program; Cancer Statistics Review, 2000-2004; National Cancer Institute, 2007). Although AML can occur at any age, adults aged 65 years and older are more likely to develop the disease than younger people are. In 2004, AML accounted for almost 15 percent of childhood acute leukemia cases (source: Surveillance, Epidemiology, and End Results [SEER] Program; 1969-2004 Counties, National Cancer Institute, 2007).

This booklet provides information about AML for patients and their families. A brief description of normal blood and marrow is provided for background, followed by a detailed description of AML and its treatment. The booklet includes a glossary to help readers understand medical terms.

Continue reading by downloading the .pdf or order a free printed copy via the online order form.

If you need assistance ordering free materials please call the Information Resource Center at (800) 955-4572 or contact your local chapter.